SCM
CLB icon

Steadfast Capital Management’s Core Laboratories CLB Stock Holding History

Steadfast Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-130,055
Closed -$6.8M – 49
2019
Q2 		$6.8M Buy
+130,055
New +$7.63M 0.09% 53

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Steadfast Capital Management's CLB Position: Q3 2019 in Review

Steadfast Capital Management sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 130,055 shares — an estimated $6.8M sold.

Steadfast Capital Management first reported a position in CLB in Q2 2019 and held it in 1 quarter. The position peaked at $6.8M in Q2 2019. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

  • Steadfast Capital Management reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
  • Steadfast Capital Management sold 130,055 Core Laboratories shares in Q3 2019, an estimated $6.8M.
  • Steadfast Capital Management first reported a position in Core Laboratories in Q2 2019 and held it in 1 quarter.
  • Steadfast Capital Management's Core Laboratories position peaked at $6.8M in Q2 2019.
  • 274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Steadfast Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.